Medtech startup NDR Medical closes $8m in series A funding

The firm aims to prepare for the expansion into the US.

Singapore-based surgical robotic firm NDR Medical Technology has raised $8m in a series A round led by Microport Scientific Corporation (MicroPort), a press release revealed.

Other investors who participated include existing investor SGInnovate, and a new investor Kava Ventures, a venture partnership founded by owners of an established medical technology distributor in Southeast Asia.

NDR will be establishing a joint venture in China with MicroPort Urocare (Jiaxing)(MicroPort Urocare), a subsidiary of MicroPort. This is said to advance NDR’s entry into the China market, tapping on existing networks and engineering resources that the partnership brings.

This investment is MicroPort’s first equity investment into a Singapore-based startup and signifies the company’s growing interest in potential investment and collaboration opportunities within the region.

The startup will use the fresh capital to prepare for the expansion into the US, regulatory submission across other major markets, and to further enhance the team’s technical capabilities and explore other clinical applications for the product.

NDR has developed an Automated Needle Targeting system known as ANT, for robotic-guided access to obtain precise targeting. The system uses artificial intelligence (AI) and medical image processing to identify the targeted lesion and perform insertion trajectory planning, with the robot executing a range of motion to assist surgeons in obtaining accurate access.